Multinational drug corporations to establish R&D centers in Korea

Many U. S. multinational drug corporations are going to make investments to Korea, exploiting great benefits from the recent KORUS FTA settlement between Korea and the United States.

KOTRA, a Korea trade promotional association, said on April 12 that "A" and "B" multinational drug corporations listed in the world top 100 enterprisers selected by Fortune magazine, one of the most famous econ...